NO20042379L - Farmasoytisk preparat omfattende faktor VII-polypeptider og PAI-1-polypeptider - Google Patents

Farmasoytisk preparat omfattende faktor VII-polypeptider og PAI-1-polypeptider

Info

Publication number
NO20042379L
NO20042379L NO20042379A NO20042379A NO20042379L NO 20042379 L NO20042379 L NO 20042379L NO 20042379 A NO20042379 A NO 20042379A NO 20042379 A NO20042379 A NO 20042379A NO 20042379 L NO20042379 L NO 20042379L
Authority
NO
Norway
Prior art keywords
polypeptides
pai
pharmaceutical preparation
factor vii
vii polypeptides
Prior art date
Application number
NO20042379A
Other languages
English (en)
Norwegian (no)
Inventor
Rasmus Rojkjaer
Original Assignee
Novo Nordisk Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk Healthcare Ag filed Critical Novo Nordisk Healthcare Ag
Publication of NO20042379L publication Critical patent/NO20042379L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36Blood coagulation or fibrinolysis factors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482Serine endopeptidases (3.4.21)
    • A61K38/4846Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • A61K38/57Protease inhibitors from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO20042379A 2001-11-09 2004-06-08 Farmasoytisk preparat omfattende faktor VII-polypeptider og PAI-1-polypeptider NO20042379L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101671 2001-11-09
PCT/DK2002/000735 WO2003039580A1 (en) 2001-11-09 2002-11-05 Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides

Publications (1)

Publication Number Publication Date
NO20042379L true NO20042379L (no) 2004-06-08

Family

ID=8160829

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042379A NO20042379L (no) 2001-11-09 2004-06-08 Farmasoytisk preparat omfattende faktor VII-polypeptider og PAI-1-polypeptider

Country Status (15)

Country Link
EP (1) EP1446146A1 (zh)
JP (1) JP2005510514A (zh)
KR (1) KR20050043733A (zh)
CN (1) CN1596122A (zh)
AU (1) AU2002340778B2 (zh)
BR (1) BR0213952A (zh)
CA (1) CA2464614A1 (zh)
CZ (1) CZ2004535A3 (zh)
HU (1) HUP0401959A3 (zh)
IL (1) IL161523A0 (zh)
NO (1) NO20042379L (zh)
PL (1) PL370118A1 (zh)
RU (1) RU2304980C2 (zh)
WO (1) WO2003039580A1 (zh)
ZA (1) ZA200403270B (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009045412A2 (en) * 2007-10-01 2009-04-09 American Diagnostica, Inc. Methods of treatment using modified plasminogen activator inhibitor type-1 molecules
CN111205244B (zh) * 2018-11-22 2023-08-18 上海科技大学 噻唑并环类化合物、其制备方法、中间体和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998058661A1 (en) * 1997-06-23 1998-12-30 Novo Nordisk A/S Use of fviia for the treatment of bleedings in patients with a normal blood clotting cascade and normal platelet function
AT409335B (de) * 1998-11-10 2002-07-25 Immuno Ag Pharmazeutisches präparat enthaltend einen rezeptor-antagonisten zur behandlung von blutgerinnungsstörungen
DE60143292D1 (de) * 2000-05-03 2010-12-02 Novo Nordisk Healthcare Ag Varianten des menschlichen Koagulationsfaktors VII

Also Published As

Publication number Publication date
ZA200403270B (en) 2004-11-08
HUP0401959A2 (hu) 2004-12-28
WO2003039580A1 (en) 2003-05-15
AU2002340778B2 (en) 2007-08-02
BR0213952A (pt) 2004-08-31
CZ2004535A3 (cs) 2005-01-12
KR20050043733A (ko) 2005-05-11
HUP0401959A3 (en) 2009-03-30
CN1596122A (zh) 2005-03-16
EP1446146A1 (en) 2004-08-18
IL161523A0 (en) 2004-09-27
CA2464614A1 (en) 2003-05-15
RU2304980C2 (ru) 2007-08-27
JP2005510514A (ja) 2005-04-21
PL370118A1 (en) 2005-05-16
RU2004117535A (ru) 2005-04-10

Similar Documents

Publication Publication Date Title
NO20044192L (no) 17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater
NO20033143L (no) Farmasoytisk preparat
DK1417175T3 (da) Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
NO20033556D0 (no) Farmasöytiske preparater
FI20011478A (fi) Farmaseuttinen koostumus
IL159015A0 (en) Polypeptides, their preparation and use
HUP0500989A2 (en) Animicrobial polypeptides and their uses
DK200300344U1 (da) Amlodipinmaleat og farmaceutisk præparat indeholdende amlodipinmaleat
NO20040235L (no) Farmasoytisk preparat som omfatter faktor VII-polypeptider og faktor XI-polypeptider
GB0108470D0 (en) Pharmaceutical compositions and their use
NO20025805L (no) Farmasöytisk preparat
EP1462455A4 (en) NOVEL PEPTIDES AND THEIR USES AS MEDICAMENTS
IL158397A0 (en) Polypeptides, their preparation and their use
IL159872A0 (en) Gmg-2 polypeptides and their use
DE60217390D1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
NO20042380L (no) Farmasoytisk preparat omfattende faktor VII-polypeptider og faktor V-polypeptider
EP1379228A4 (en) (Z) -STYRYLBENZYLSULPONES AND THEIR PHARMACEUTICAL APPLICATIONS
NO20042379L (no) Farmasoytisk preparat omfattende faktor VII-polypeptider og PAI-1-polypeptider
IL156711A0 (en) Peptide derivatives and pharmaceutical compositions containing the same
DE10291905D2 (de) Pharmazeutische Zusammensetzung
NO20015534D0 (no) Farmasöytisk blandeapparat
DE10107261B4 (de) Pharmazeutische Zusammensetzung
EP1437363A4 (en) MEDICINAL TRANSPORT AND USE THEREOF
AU2002340777A1 (en) Pharmaceutical composition comprising factor vii polypeptides and tafi polypeptides
AU2002340784A1 (en) Pharmaceutical composition comprising factor vii polypeptides and alpha2 -antiplasmin polypeptides